Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Nvidia (NVDA) reported Q3 results that beat consensus and
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Nvidia (NVDA) reported Q3 results that beat consensus and
הפירמה ביצעה את ההתאמה הזו לאחר ש-Syndax (SNDX) דיווחו על תוצאות מאכזבות עבור mNPM-1 revumenib ולאחר תנאי העסקה שהוכרזו עם Kyowa Kirin (KYKOF), לפי האנליסטית.
Scotiabank lowered the firm’s price target on Kura Oncology (KURA) to $18 from $22 and keeps a Sector Perform rating on the shares. The firm adjusted its price target on
Wedbush analyst David Nierengarten initiated coverage with a Buy rating on Kura Oncology (KURA – Research Report) today and set a price target of $34.00. The company’s shares closed yesterday
Wedbush lowered the firm’s price target on Kura Oncology (KURA) to $34 from $37 and keeps an Outperform rating on the shares. The company entered a major development and commercialization